Global Technologies launches Primecare Supply, signs two agreements; Flippen named Chairman and CEO

GLOBAL TECHNOLOGIES LTD

Launched Primecare Supply, LLC subsidiary, entering FDA-compliant pharmaceutical distribution and digital wellness.
Primecare signed a Revenue Share Agreement retaining 75% of gross margin above supplier floor price.
Signed Master Licensing Agreement with AI partner (2.5% transaction fee, 24-month term) for digital tools.
H. Wyatt Flippen appointed Chairman in addition to CEO; President of clean energy subsidiary removed.
Pivot driven by FDA regulatory shifts affecting GLP-1 compounding; focus on scalable, revenue-focused platforms.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.